Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2022-07-14
2022-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles
NCT04124692
Safety and Effectiveness of Sculptra Aesthetic for Correction of Nasolabial Folds.
NCT03780244
Sculptra Aesthetic Post-Approval Study
NCT02425943
Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
NCT04132518
Open Label Extension for 43USSA1812
NCT04595331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Females/Males treated with Sculptra Aesthetic in non-facial areas
Sculptra Aesthetic administration in non-facial areas
Sculptra Aesthetic
Sculptra Aesthetic in non-facial areas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sculptra Aesthetic
Sculptra Aesthetic in non-facial areas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects with available information about treatment dates and treatment procedures
Exclusion Criteria
* Other conditions that in the Investigator's opinion would exclude the subject from participation ; the condition should be recorded.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Galderma Research Site
Pasadena, California, United States
Galderma Research Site
San Diego, California, United States
Galderma Research Site
Solana Beach, California, United States
Galderma Research Site
Coral Gables, Florida, United States
Galderma Research Site
Fort Lauderdale, Florida, United States
Site Coordinator
New York, New York, United States
Galderma Research Site
New York, New York, United States
Galderma Research Site
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
43USSA2110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.